• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Drug Makers Shifting Towards Targeted Cancer Drugs

Article

The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells.

PFE

+1.61%

JNJ

+0.31%

Pfizer Inc. , GlaxoSmithKline PLC (GSK, GSK.LN) and Johnson & Johnson are among those whose drugs will be highlighted when the American Society of Clinical Oncology on Wednesday releases summaries of more than 4,500 cancer studies, two weeks ahead of ASCO's annual scientific meeting.

Read the full story: http://hcp.lv/L7lWOL

Source: Market Watch (The Wall Street Journal)

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.